Stromal interaction molecule 1 (STIM1) Human shRNA Plasmid Kit (Locus ID 6786)
CAT#: TG309049
STIM1 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 4,790.00
货期*
现货
规格
Cited in 3 publications. |
Product images
经常一起买 (2)
Specifications
Product Data | |
Product Name | Stromal interaction molecule 1 (STIM1) Human shRNA Plasmid Kit (Locus ID 6786) |
Locus ID | 6786 |
UniProt ID | Q13586 |
Synonyms | D11S4896E; GOK; IMD10; STRMK; TAM; TAM1 |
Vector | pGFP-V-RS |
Format | Retroviral plasmids |
Kit Components | STIM1 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector(Gene ID = 6786). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pGFP-V-RS Vector, TR30013, included for free. |
RefSeq | NM_001277961, NM_001277962, NM_003156, NM_003156.1, NM_003156.2, NM_003156.3, NM_001277962.1, NM_001277961.1, BC021300, BC019905, BM127091, NM_001277961.3, NM_001277962.2, NM_003156.4 |
Summary | This gene encodes a type 1 transmembrane protein that mediates Ca2+ influx after depletion of intracellular Ca2+ stores by gating of store-operated Ca2+ influx channels (SOCs). It is one of several genes located in the imprinted gene domain of 11p15.5, an important tumor-suppressor gene region. Alterations in this region have been associated with the Beckwith-Wiedemann syndrome, Wilms tumor, rhabdomyosarcoma, adrenocrotical carcinoma, and lung, ovarian, and breast cancer. This gene may play a role in malignancies and disease that involve this region, as well as early hematopoiesis, by mediating attachment to stromal cells. Mutations in this gene are associated with fatal classic Kaposi sarcoma, immunodeficiency due to defects in store-operated calcium entry (SOCE) in fibroblasts, ectodermal dysplasia and tubular aggregate myopathy. This gene is oriented in a head-to-tail configuration with the ribonucleotide reductase 1 gene (RRM1), with the 3' end of this gene situated 1.6 kb from the 5' end of the RRM1 gene. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (3)
The use of this RNAi has been cited in the following citations: |
---|
Role of STIM2 and Orai proteins in regulating TRPC1 channel activity upon calcium store depletion
,Shalygin, A;Kolesnikov, D;Glushankova, L;Gusev, K;Skopin, A;Skobeleva, K;Kaznacheyeva, EV;,
Cell calcium
,PubMed ID 34157631
[STIM1]
|
Amplified lipid rafts of malignant cells constitute a target for inhibition of aberrantly active NFAT and melanoma tumor growth by the aminobisphosphonate zoledronic acid
,Levin Gromiko, U;Koshelev, V;Kushnir, P;Fedida-Metula, S;Voronov, E;Fishman, D;,
Carcinogenesis
,PubMed ID 25142972
[STIM1]
|
Molecular mechanisms of spontaneous and directed mast cell motility
,Jinmin Lee, Sarah L. Veatch, Barbara Baird, and David Holowka,
J. Leukoc. Biol., Nov 2012; 92: 1029 - 1041.
[STIM1]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...